Products
Research Areas
COVID-19
Resources
Login
Quick Order
Cart
Login
Registration enables users to use special features of this website, such as past
order histories, retained contact details for faster checkout, review submissions, and special promotions.


Fields marked with a * are required.

Login
Quick Order
Contact Us

Locations


Orders Processing,
Shipping & Receiving,
Warehouse

2 Shaker Rd Suites
B001/B101
Shirley, MA 01464


Production Lab

Floor 6, Suite 620
20700 44th Avenue W
Lynnwood, WA 98036

Telephone Numbers



Tel: +1 (206) 374-1102
Fax: +1 (206) 577-4565

Contact Us



Additional Contact Details

Login
Registration enables users to use special features of this website, such as past
order histories, retained contact details for faster checkout, review submissions, and special promotions.


Fields marked with a * are required.

Login
Quick Order
Catalog Number Size Price
LS-G3890-50 50 µg $442 
LAG3 Protein - Binding of LAG-3 (human):Fc (human) (rec.) and EBV-transformed B-cells are incubated with either an anti-MHC class II MAb (10 ug/ml) or LAG-3 (human):Fc (human) (rec.) (10 ug/ml) for 30 minutes. at 4°C in PBS/1% BSA. The cells are then stained for 30 minutes. at 4°C with FITC-labeled goat anti-human Fc antibodies.
LAG3 Protein - LAG 3 (human):Fc (human) (rec.)-induced dendritic cells (DC) maturation. Method: Immature DCs derived from human monocytes, resuspended at 1x10^6 cells/ml in complete culture medium, are incubated with LAG-3 (human):Fc (human) (rec.) (10ug/ml), LPS (positive control, 5ug/ml) or human IgG1 (isotype-matched negative control, 10ug/ml) for 48 hours. DC maturation induced by LAG-3 (human):Fc (human) (rec.) binding to MHC class II or LPS is assessed by the increased expression of MHC Class II, CD80, CD83, CD86 and CD40.
LAG3 Protein - Binding of LAG-3 (human):Fc (human) (rec.) and EBV-transformed B-cells are incubated with either an anti-MHC class II MAb (10 ug/ml) or LAG-3 (human):Fc (human) (rec.) (10 ug/ml) for 30 minutes. at 4°C in PBS/1% BSA. The cells are then stained for 30 minutes. at 4°C with FITC-labeled goat anti-human Fc antibodies.
LAG3 Protein - LAG 3 (human):Fc (human) (rec.)-induced dendritic cells (DC) maturation. Method: Immature DCs derived from human monocytes, resuspended at 1x10^6 cells/ml in complete culture medium, are incubated with LAG-3 (human):Fc (human) (rec.) (10ug/ml), LPS (positive control, 5ug/ml) or human IgG1 (isotype-matched negative control, 10ug/ml) for 48 hours. DC maturation induced by LAG-3 (human):Fc (human) (rec.) binding to MHC class II or LPS is assessed by the increased expression of MHC Class II, CD80, CD83, CD86 and CD40.
1 of 2
2 of 2

Human LAG3 Protein (Recombinant Human IgG1 Fc) - LS-G3890

Human LAG3 Protein (Recombinant Human IgG1 Fc) - LS-G3890

Description:
LAG3 Protein LS-G3890 is a Recombinant Human LAG3 produced in CHO Cells with Human IgG1 Fc tag(s). It is low in endotoxin; Less than 0.1 EU/µg protein (determined by LAL method). For Research Use Only
Price
Catalog Number
$442
LS-G3890-50
Toll Free North America
206-374-1102
For Research Use Only

Overview

Description:
LAG3 Protein LS-G3890 is a Recombinant Human LAG3 produced in CHO Cells with Human IgG1 Fc tag(s). It is low in endotoxin; Less than 0.1 EU/µg protein (determined by LAL method). For Research Use Only

Specifications

Type
Recombinant Protein
Target
LAG3
Synonyms
LAG3 | CD223 antigen | LAG-3 | Protein FDC | CD223 | FDC | Lymphocyte-activation gene 3
Species
Human
Modifications
Unmodified
Conjugations
Unconjugated
Tag
Human IgG1 Fc
Predicted Molecular Weight
~80kDa (SDS-PAGE)
Expression System
CHO Cells
Source Species
Hamster-Chinese
Purification
Greater than 99% by SDS-PAGE
Bio-Activity
Inhibits binding of MAb to LAG-3 (human) to LAG-3. Induces maturation of human dendritic cells.
Endotoxin
Less than 0.1 EU/µg protein (determined by LAL method).
Presentation
PBS
Storage
Store at 4°C for immediate use, or aliquot and store at -20°C for up to 6 months. Avoid freeze-thaw cycles.
Restrictions
For research use only. Intended for use by laboratory professionals.
Guarantee
This protein carries the LSBio 100% Guarantee.
LSBio Guarantee
About LAG3
P18627 NM_002286 P18627

Publications (0)

Customer Reviews (0)

Images

Functional Assay

LAG3 Protein - Binding of LAG-3 (human):Fc (human) (rec.) and EBV-transformed B-cells are incubated with either an anti-MHC class II MAb (10 ug/ml) or LAG-3 (human):Fc (human) (rec.) (10 ug/ml) for 30 minutes. at 4°C in PBS/1% BSA. The cells are then stained for 30 minutes. at 4°C with FITC-labeled goat anti-human Fc antibodies.
Binding of LAG-3 (human):Fc (human) (rec.) and EBV-transformed B-cells are incubated with either an anti-MHC class II MAb (10 ug/ml) or LAG-3 (human):Fc (human) (rec.) (10 ug/ml) for 30 minutes. at 4°C in PBS/1% BSA. The cells are then stained for 30 minutes. at 4°C with FITC-labeled goat anti-human Fc antibodies.

Functional Assay

LAG3 Protein - LAG 3 (human):Fc (human) (rec.)-induced dendritic cells (DC) maturation. Method: Immature DCs derived from human monocytes, resuspended at 1x10^6 cells/ml in complete culture medium, are incubated with LAG-3 (human):Fc (human) (rec.) (10ug/ml), LPS (positive control, 5ug/ml) or human IgG1 (isotype-matched negative control, 10ug/ml) for 48 hours. DC maturation induced by LAG-3 (human):Fc (human) (rec.) binding to MHC class II or LPS is assessed by the increased expression of MHC Class II, CD80, CD83, CD86 and CD40.
LAG 3 (human):Fc (human) (rec.)-induced dendritic cells (DC) maturation. Method: Immature DCs derived from human monocytes, resuspended at 1x10^6 cells/ml in complete culture medium, are incubated with LAG-3 (human):Fc (human) (rec.) (10ug/ml), LPS (positive control, 5ug/ml) or human IgG1 (isotype-matched negative control, 10ug/ml) for 48 hours. DC maturation induced by LAG-3 (human):Fc (human) (rec.) binding to MHC class II or LPS is assessed by the increased expression of MHC Class II, CD80, CD83, CD86 and CD40.

Functional Assay

LAG3 Protein - Binding of LAG-3 (human):Fc (human) (rec.) and EBV-transformed B-cells are incubated with either an anti-MHC class II MAb (10 ug/ml) or LAG-3 (human):Fc (human) (rec.) (10 ug/ml) for 30 minutes. at 4°C in PBS/1% BSA. The cells are then stained for 30 minutes. at 4°C with FITC-labeled goat anti-human Fc antibodies.
Binding of LAG-3 (human):Fc (human) (rec.) and EBV-transformed B-cells are incubated with either an anti-MHC class II MAb (10 ug/ml) or LAG-3 (human):Fc (human) (rec.) (10 ug/ml) for 30 minutes. at 4°C in PBS/1% BSA. The cells are then stained for 30 minutes. at 4°C with FITC-labeled goat anti-human Fc antibodies.

Functional Assay

LAG3 Protein - LAG 3 (human):Fc (human) (rec.)-induced dendritic cells (DC) maturation. Method: Immature DCs derived from human monocytes, resuspended at 1x10^6 cells/ml in complete culture medium, are incubated with LAG-3 (human):Fc (human) (rec.) (10ug/ml), LPS (positive control, 5ug/ml) or human IgG1 (isotype-matched negative control, 10ug/ml) for 48 hours. DC maturation induced by LAG-3 (human):Fc (human) (rec.) binding to MHC class II or LPS is assessed by the increased expression of MHC Class II, CD80, CD83, CD86 and CD40.
LAG 3 (human):Fc (human) (rec.)-induced dendritic cells (DC) maturation. Method: Immature DCs derived from human monocytes, resuspended at 1x10^6 cells/ml in complete culture medium, are incubated with LAG-3 (human):Fc (human) (rec.) (10ug/ml), LPS (positive control, 5ug/ml) or human IgG1 (isotype-matched negative control, 10ug/ml) for 48 hours. DC maturation induced by LAG-3 (human):Fc (human) (rec.) binding to MHC class II or LPS is assessed by the increased expression of MHC Class II, CD80, CD83, CD86 and CD40.

Functional Assay

LAG3 Protein - Binding of LAG-3 (human):Fc (human) (rec.) and EBV-transformed B-cells are incubated with either an anti-MHC class II MAb (10 ug/ml) or LAG-3 (human):Fc (human) (rec.) (10 ug/ml) for 30 minutes. at 4°C in PBS/1% BSA. The cells are then stained for 30 minutes. at 4°C with FITC-labeled goat anti-human Fc antibodies.
Binding of LAG-3 (human):Fc (human) (rec.) and EBV-transformed B-cells are incubated with either an anti-MHC class II MAb (10 ug/ml) or LAG-3 (human):Fc (human) (rec.) (10 ug/ml) for 30 minutes. at 4°C in PBS/1% BSA. The cells are then stained for 30 minutes. at 4°C with FITC-labeled goat anti-human Fc antibodies.

Functional Assay

LAG3 Protein - LAG 3 (human):Fc (human) (rec.)-induced dendritic cells (DC) maturation. Method: Immature DCs derived from human monocytes, resuspended at 1x10^6 cells/ml in complete culture medium, are incubated with LAG-3 (human):Fc (human) (rec.) (10ug/ml), LPS (positive control, 5ug/ml) or human IgG1 (isotype-matched negative control, 10ug/ml) for 48 hours. DC maturation induced by LAG-3 (human):Fc (human) (rec.) binding to MHC class II or LPS is assessed by the increased expression of MHC Class II, CD80, CD83, CD86 and CD40.
LAG 3 (human):Fc (human) (rec.)-induced dendritic cells (DC) maturation. Method: Immature DCs derived from human monocytes, resuspended at 1x10^6 cells/ml in complete culture medium, are incubated with LAG-3 (human):Fc (human) (rec.) (10ug/ml), LPS (positive control, 5ug/ml) or human IgG1 (isotype-matched negative control, 10ug/ml) for 48 hours. DC maturation induced by LAG-3 (human):Fc (human) (rec.) binding to MHC class II or LPS is assessed by the increased expression of MHC Class II, CD80, CD83, CD86 and CD40.

Functional Assay

LAG3 Protein - Binding of LAG-3 (human):Fc (human) (rec.) and EBV-transformed B-cells are incubated with either an anti-MHC class II MAb (10 ug/ml) or LAG-3 (human):Fc (human) (rec.) (10 ug/ml) for 30 minutes. at 4°C in PBS/1% BSA. The cells are then stained for 30 minutes. at 4°C with FITC-labeled goat anti-human Fc antibodies.
Binding of LAG-3 (human):Fc (human) (rec.) and EBV-transformed B-cells are incubated with either an anti-MHC class II MAb (10 ug/ml) or LAG-3 (human):Fc (human) (rec.) (10 ug/ml) for 30 minutes. at 4°C in PBS/1% BSA. The cells are then stained for 30 minutes. at 4°C with FITC-labeled goat anti-human Fc antibodies.

Functional Assay

LAG3 Protein - LAG 3 (human):Fc (human) (rec.)-induced dendritic cells (DC) maturation. Method: Immature DCs derived from human monocytes, resuspended at 1x10^6 cells/ml in complete culture medium, are incubated with LAG-3 (human):Fc (human) (rec.) (10ug/ml), LPS (positive control, 5ug/ml) or human IgG1 (isotype-matched negative control, 10ug/ml) for 48 hours. DC maturation induced by LAG-3 (human):Fc (human) (rec.) binding to MHC class II or LPS is assessed by the increased expression of MHC Class II, CD80, CD83, CD86 and CD40.
LAG 3 (human):Fc (human) (rec.)-induced dendritic cells (DC) maturation. Method: Immature DCs derived from human monocytes, resuspended at 1x10^6 cells/ml in complete culture medium, are incubated with LAG-3 (human):Fc (human) (rec.) (10ug/ml), LPS (positive control, 5ug/ml) or human IgG1 (isotype-matched negative control, 10ug/ml) for 48 hours. DC maturation induced by LAG-3 (human):Fc (human) (rec.) binding to MHC class II or LPS is assessed by the increased expression of MHC Class II, CD80, CD83, CD86 and CD40.

Request SDS/MSDS

To request an SDS/MSDS form for this product, please contact our Technical Support department at:

Technical.Support@LSBio.com

Requested From: United States
Date Requested: 4/25/2024